Literature DB >> 9840557

Obstetric events leading to anal sphincter damage.

V Donnelly1, M Fynes, D Campbell, H Johnson, P R O'Connell, C O'Herlihy.   

Abstract

OBJECTIVE: To identify the obstetric factors relating to anal sphincter injury at first vaginal delivery by prospective cohort study of primiparous women.
METHODS: We compared the results of a bowel function questionnaire and anal vector manometry before and 6 weeks after delivery in 184 primiparous women. Postpartum, pudendal nerve conduction latency was measured in all women, and anal endosonography was performed in 81 with altered fecal continence or abnormal physiology.
RESULTS: Sixteen (9%) women, none of whom had altered fecal continence, were delivered by cesarean. After vaginal delivery, 42 of 168 (25%) women had impairment of fecal continence and 76 of 168 (45%) women had abnormal anal physiology. Instrumental vaginal delivery was associated with an 8.1-fold (95% confidence interval [CI] 2.7, 24.0; P < .001) risk of anal sphincter injury and a 7.2-fold (95% CI 2.8, 18.6; P < .001) risk of symptoms. Duration of the second stage of labor beyond 60 minutes led to a 1.7-fold (95% CI 1.14, 2.48; P;< .01) risk of anal sphincter injury and a 1.6-fold (95% CI 1.03, 2.6, P = .01) risk of symptoms. Epidural analgesia, used in 58% of vaginal deliveries, prolonged the second stage of labor (P = .004; odds ratio [OR] 7.7; 95% CI 4.0, 14.7) and was associated with increased risk of sphincter injury (P = .02; OR 2.1; 95% CI 1.1, 4.0) and of symptoms (P = .02; OR 2.0; 95% CI 1.1, 3.7).
CONCLUSION: Instrumental delivery and a second stage of labor prolonged by epidural analgesia are the obstetric factors that pose the greatest risk of injury to the anal sphincter mechanism in primiparous vaginal delivery.

Entities:  

Mesh:

Year:  1998        PMID: 9840557     DOI: 10.1016/s0029-7844(98)00255-5

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  29 in total

1.  Cesarean section versus forceps-assisted vaginal birth: it's time to include pelvic injury in the risk-benefit equation.

Authors:  Scott A Farrell
Journal:  CMAJ       Date:  2002-02-05       Impact factor: 8.262

2.  Postpartum urinary incontinence.

Authors:  Linda Brubaker
Journal:  BMJ       Date:  2002-05-25

3.  Low current electrical stimulation upregulates cytokine expression in the anal sphincter.

Authors:  Levilester Salcedo; Lei Lian; Hai-Hong Jiang; Nikolai Sopko; Marc Penn; Margot Damaser; Massarat Zutshi
Journal:  Int J Colorectal Dis       Date:  2011-10-18       Impact factor: 2.571

4.  Obstetric factors associated with levator ani muscle injury after vaginal birth.

Authors:  Rohna Kearney; Janis M Miller; James A Ashton-Miller; John O L DeLancey
Journal:  Obstet Gynecol       Date:  2006-01       Impact factor: 7.661

5.  Decreased rate of obstetrical anal sphincter laceration is associated with change in obstetric practice.

Authors:  Steven M Minaglia; Begüm Ozel; Nicole M Gatto; Lisa Korst; Daniel R Mishell; David A Miller
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-03-28

6.  Quantification of friction force reduction induced by obstetric gels.

Authors:  Robert Riener; Kerstin Leypold; Andreas Brunschweiler; Andreas Schaub; Ulrich Bleul; Peter Wolf
Journal:  Med Biol Eng Comput       Date:  2009-02-24       Impact factor: 2.602

7.  Evaluation of anal incontinence: minimal approach, maximal effectiveness.

Authors:  Harry T Papaconstantinou
Journal:  Clin Colon Rectal Surg       Date:  2005-02

8.  Anal physiology testing in fecal incontinence: is it of any value?

Authors:  Massarat Zutshi; Levilester Salcedo; Jeffrey Hammel; Tracy Hull
Journal:  Int J Colorectal Dis       Date:  2009-11-10       Impact factor: 2.571

9.  Behavioural studies of faecal continence in the rat.

Authors:  B K Soetan; P R O'Connell; J F X Jones
Journal:  Ir J Med Sci       Date:  2014-01-24       Impact factor: 1.568

10.  Obstetric risk factors and pelvic floor dysfunction 20 years after first delivery.

Authors:  Lucia M Dolan; Paul Hilton
Journal:  Int Urogynecol J       Date:  2010-01-06       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.